Skip to content

Author

Kai-Yuan Guo

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer.

A critical role is revealed for MMGT1 in shaping the TNBC immune microenvironment and targeting MMGT1 represents a promising strategy to improve anti-PD-1 immunotherapy outcomes, suggesting that targeting MMGT1 represents a promising strategy to improve anti-PD-1 immunotherapy outcomes.

Shao-Qing Liu, Hong-Bing Liu, Meng-Ying Zhang et al. · 0 citations
Open access Sep 2026

Myeloid-derived suppressor cells confer stemness to esophageal cancer cells through the HNF1A/CXCL1 signaling axis

It is shown that MDSCs accelerate ESCC growth in both immunocompetent and T cell-deficient mice, indicating an intrinsic tumor-promoting program and targeting this pathway may complement T cell-focused therapies in ESCC.

Guo-Hui Qin, Ping-Chuan Ma, Sha-Sha Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.